Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:2,4-Dinitrophenol)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteUnits(range)
ST002747 AN004455 Evolutionary genomics identifies host-directed therapeutics to treat intracellular bacterial infections Cultured cells Human CZ Biohub counts, height
ST002747 AN004455 Evolutionary genomics identifies host-directed therapeutics to treat intracellular bacterial infections Cultured cells Rickettsia parkeri CZ Biohub counts, height
ST000291 AN000465 LC-MS Based Approaches to Investigate Metabolomic Differences in the Urine of Young Women after Drinking Cranberry Juice or Apple Juice Urine Human University of Florida Peak area
ST000446 AN000698 Heterologous expression and detection of Apratoxins in E. coli Bacterial cells E. coli University of Florida Peak area
ST000248 AN000392 Metabolic heterogeneity in Glioblastoma Glioma cells Human Cancer University of Florida Peak height
ST000286 AN000455 Mouse skeletal myotube chronic low-frequency stimulation Myotubes Mouse University of Florida Peak height
ST000552 AN000844 Metabolite signatures in trauma patients with venous thromboembolism (VTE) Blood Human Trauma University of Florida Peak height
ST000919 AN001507 Investigating Eicosanoids Implications on the Blood Pressure Response to Thiazide Diuretics Blood Human University of Florida Peak height
ST000957 AN001571 Global metabolomics of human milk fractions Breast milk Human Obesity University of Florida Peak height
ST001754 AN002858 Metabolomic Analysis of Canine Diabetes (part-II) Blood Dog Diabetes University of Florida Peak Height
ST000421 AN000664 ms3076 T1D poor glycemic control and control samples Blood Human Diabetes Mayo Clinic Peak intensity
ST000422 AN000668 Type 1 Diabetes good glycemic control and controls samples Blood Human Diabetes Mayo Clinic Peak intensity
ST000422 AN000670 Type 1 Diabetes good glycemic control and controls samples Blood Human Diabetes Mayo Clinic Peak intensity
ST000046 AN000078 Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) Blood Human Alzheimers disease Mayo Clinic Raw MS Intensities
ST000046 AN000079 Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) Blood Human Alzheimers disease Mayo Clinic Raw MS Intensities
ST000047 AN000082 Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) Cerebrospinal fluid Human Alzheimers disease Mayo Clinic Raw MS Intensities
ST000047 AN000083 Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) Cerebrospinal fluid Human Alzheimers disease Mayo Clinic Raw MS Intensities
  logo